Replies to post #112021 on Biotech Values

[olddogwithnewtrix]

MNTA would move to 20 like a hot knife through butter. It's just inching for a reason to go higher.

[DewDiligence]

This is not a question of Teva’s wanting to be honest with investors, but rather that MNTA’s lawsuit against Teva is now serving the business purpose I posited in #msg-57304268. Regards, Dew